{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T18:45:31Z","timestamp":1769107531981,"version":"3.49.0"},"reference-count":197,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T00:00:00Z","timestamp":1684886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Biosci."],"abstract":"<jats:p>X-ray crystallography and structure-based drug discovery have played a major role in the discovery of antisickling agents that target hemoglobin (Hb) for the treatment of sickle cell disease (SCD). Sickle cell disease, the most common inherited hematologic disorder, occurs as a result of a single point mutation of \u03b2Glu6 in normal human adult hemoglobin (HbA) to \u03b2Val6 in sickle hemoglobin (HbS). The disease is characterized by polymerization of HbS and sickling of red blood cells (RBCs), leading to several secondary pathophysiologies, including but not limited to vaso-occlusion, hemolytic anemia, oxidative stress, inflammation, stroke, pain crisis, and organ damage. Despite the fact that SCD was the first disease to have its molecular basis established, the development of therapies was for a very long time a challenge and took several decades to find therapeutic agents. The determination of the crystal structure of Hb by Max Perutz in the early 60s, and the pioneering X-ray crystallography research by Donald J. Abraham in the early 80s, which resulted in the first structures of Hb in complex with small molecule allosteric effectors of Hb, gave much hope that structure-based drug discovery (SBDD) could be used to accelerate development of antisickling drugs that target the primary pathophysiology of hypoxia-induced HbS polymerization to treat SCD. This article, which is dedicated to Donald J. Abraham, briefly reviews structural biology, X-ray crystallography and structure-based drug discovery from the perspective of Hb. The review also presents the impact of X-ray crystallography in SCD drug development using Hb as a target, emphasizing the major and important contributions by Don Abraham in this field.<\/jats:p>","DOI":"10.3389\/fmolb.2023.1136970","type":"journal-article","created":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T05:33:06Z","timestamp":1684906386000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["X-ray crystallography and sickle cell disease drug discovery\u2014a tribute to Donald Abraham"],"prefix":"10.3389","volume":"10","author":[{"given":"Akua K.","family":"Donkor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piyusha P.","family":"Pagare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed H. AL","family":"Mughram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin K.","family":"Safo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1107\/S0907444911036353","article-title":"Crystallographic analysis of human hemoglobin elucidates the structural basis of the potent and dual antisickling activity of pyridyl derivatives of vanillin","volume":"67","author":"Abdulmalik","year":"2011","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"B2","doi-asserted-by":"publisher","first-page":"20277","DOI":"10.1038\/s41598-020-77171-2","article-title":"VZHE-039, a novel antisickling agent that prevents erythrocyte sickling under both hypoxic and anoxic conditions","volume":"10","author":"Abdulmalik","year":"2020","journal-title":"Sci. Rep."},{"key":"B3","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/j.1365-2141.2004.05332.x","article-title":"5-hydroxymethyl-2-furfural modifies intracellular sickle haemoglobin and inhibits sickling of red blood cells","volume":"128","author":"Abdulmalik","year":"2005","journal-title":"Br. J. Haematol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/ajh.20184","article-title":"Characterization of hemoglobin bassett (alpha94Asp-->Ala), a variant with very low oxygen affinity","volume":"77","author":"Abdulmalik","year":"2004","journal-title":"Am. J. Hematol."},{"key":"B5","article-title":"Sickle cell anemia treatment and compound","author":"Abraham","year":"1984"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1021\/jm00378a005","article-title":"Design, synthesis, and testing of potential antisickling agents. 5. Disubstituted benzoic acids designed for the donor site and proline salicylates designed for the acceptor site","volume":"27","author":"Abraham","year":"","journal-title":"J. Med. Chem."},{"key":"B7","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1021\/jm00374a006","article-title":"Design, synthesis, and testing of potential antisickling agents. 4. Structure-activity relationships of benzyloxy and phenoxy acids","volume":"27","author":"Abraham","year":"","journal-title":"J. Med. Chem."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1021\/jm00351a002","article-title":"Design, synthesis, and testing of potential antisickling agents. 1. Halogenated benzyloxy and phenoxy acids","volume":"25","author":"Abraham","year":"1982","journal-title":"J. Med. Chem."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1182\/blood.v77.6.1334.1334","article-title":"Vanillin, a potential agent for the treatment of sickle cell anemia","volume":"77","author":"Abraham","year":"1991","journal-title":"Blood"},{"key":"B10","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1021\/jm00358a017","article-title":"Design, synthesis, and testing of antisickling agents. 2. Proline derivatives designed for the donor site","volume":"26","author":"Abraham","year":"","journal-title":"J. Med. Chem."},{"key":"B11","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1073\/pnas.80.2.324","article-title":"Physiological and x-ray studies of potential antisickling agents","volume":"80","author":"Abraham","year":"","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B12","doi-asserted-by":"publisher","first-page":"15006","DOI":"10.1021\/bi00046a007","article-title":"How allosteric effectors can bind to the same protein residue and produce opposite shifts in the allosteric equilibrium","volume":"34","author":"Abraham","year":"1995","journal-title":"Biochemistry"},{"key":"B13","doi-asserted-by":"publisher","first-page":"9141","DOI":"10.1021\/bi00153a005","article-title":"Allosteric modifiers of hemoglobin: 2-[4-[[(3,5-disubstituted anilino)carbonyl]methyl]phenoxy]-2-methylpropionic acid derivatives that lower the oxygen affinity of hemoglobin in red cell suspensions, in whole blood, and in vivo in rats","volume":"31","author":"Abraham","year":"1992","journal-title":"Biochemistry"},{"key":"B14","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/978-3-030-41769-7_14","article-title":"Structure, function and allostery","volume-title":"Vertebrate and invertebrate respiratory proteins, lipoproteins and other body fluid proteins subcellular Biochemistry","author":"Ahmed","year":"2020"},{"key":"B15","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1002\/jcp.22195","article-title":"Sickle cell anemia and vascular dysfunction: The nitric oxide connection","volume":"224","author":"Akinsheye","year":"2010","journal-title":"J. Cell. Physiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"696","DOI":"10.3390\/biom12050696","article-title":"Design, synthesis, and antisickling investigation of a nitric oxide-releasing prodrug of 5HMF for the treatment of sickle cell disease","volume":"12","author":"Alhashimi","year":"2022","journal-title":"Biomolecules"},{"key":"B17","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/ajh.21162","article-title":"Prevalence and risk factors for pulmonary artery systolic hypertension among sickle cell disease patients in Nigeria","volume":"83","author":"Aliyu","year":"2008","journal-title":"Am. J. Hematol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"7448","DOI":"10.3390\/ijms23137448","article-title":"Metabolic reprogramming in sickle cell diseases: Pathophysiology and drug discovery opportunities","volume":"23","author":"Alramadhani","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.disamonth.2017.12.003","article-title":"Sickle cell disease; an overview of the disease and its systemic effects","volume":"64","author":"Alrayyes","year":"2018","journal-title":"Dis. Mon."},{"key":"B22","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/237146a0","article-title":"X-ray diffraction study of binding of 2,3-diphosphoglycerate to human deoxyhaemoglobin","volume":"237","author":"Arnone","year":"1972","journal-title":"Nature"},{"key":"B23","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1046\/j.1365-2141.1996.d01-1744.x","article-title":"Tucaresol increases oxygen affinity and reduces haemolysis in subjects with sickle cell anaemia","volume":"93","author":"Arya","year":"1996","journal-title":"Br. J. Haematol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1056\/NEJMoa1611770","article-title":"Crizanlizumab for the prevention of pain crises in sickle cell disease","volume":"376","author":"Ataga","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/0022-2836(79)90277-8","article-title":"Haemoglobin: The structural changes related to ligand binding and its allosteric mechanism","volume":"129","author":"Baldwin","year":"1979","journal-title":"J. Mol. Biol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/s1570-0232(03)00202-2","article-title":"Determination of haemoglobin A(1c) by liquid chromatography using a new cation-exchange column","volume":"791","author":"Beatriz de la Calle Gunti\u00f1as","year":"2003","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life. Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/j.1476-5381.1984.tb10775.x","article-title":"Substituted benzaldehydes designed to increase the oxygen affinity of human haemoglobin and inhibit the sickling of sickle erythrocytes","volume":"82","author":"Beddell","year":"1984","journal-title":"Br. J. Pharmacol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"3953","DOI":"10.1182\/blood-2002-10-3313","article-title":"Transgenic sickle mice have vascular inflammation","volume":"101","author":"Belcher","year":"2003","journal-title":"Blood"},{"key":"B29","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/221618a0","article-title":"Intracellular organic phosphates as regulators of oxygen release by haemoglobin","volume":"221","author":"Benesch","year":"1969","journal-title":"Nature"},{"key":"B30","doi-asserted-by":"publisher","first-page":"8169","DOI":"10.1016\/s0021-9258(19)86871-0","article-title":"Alpha Chain mutations with opposite effects on the gelation of hemoglobin S","volume":"254","author":"Benesch","year":"1979","journal-title":"J. Biol. Chem."},{"key":"B31","article-title":"\u201cHemoglobin transports oxygen efficiently by binding oxygen cooperatively","volume-title":"Biochemistry","author":"Berg","year":"2002"},{"key":"B32","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/jmri.20120","article-title":"Nobel prizes for nuclear magnetic resonance: 2003 and historical perspectives","volume":"20","author":"Boesch","year":"2004","journal-title":"J. Magn. Reson. Imaging"},{"key":"B33","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/228551a0","article-title":"Three dimensional Fourier synthesis of horse deoxyhaemoglobin at 2.8 Angstrom units resolution","volume":"228","author":"Bolton","year":"1970","journal-title":"Nature"},{"key":"B34","doi-asserted-by":"publisher","first-page":"15021","DOI":"10.1021\/bi00046a008","article-title":"Bisaldehyde allosteric effectors as molecular ratchets and probes","volume":"34","author":"Boyiri","year":"1995","journal-title":"Biochemistry"},{"key":"B37","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/0301-4622(86)85006-2","article-title":"A cooperative model for ligand binding to biological macromolecules as applied to oxygen carriers","volume":"23","author":"Brunori","year":"1986","journal-title":"Biophys. Chem."},{"key":"B38","volume-title":"Hemoglobin\u2013molecular, genetic, and clinical aspects","author":"Bunn","year":"1986"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1172\/JCI106324","article-title":"The interaction of 2,3-diphosphoglycerate with various human hemoglobins","volume":"49","author":"Bunn","year":"1970","journal-title":"J. Clin. Invest."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1056\/NEJM197006182822507","article-title":"Control of hemoglobin function within the red cell","volume":"282","author":"Bunn","year":"1970","journal-title":"N. Engl. J. Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3109\/00313021003631197","article-title":"Haemoglobin Stanleyville II modifies sickle disease phenotype","volume":"42","author":"Burchall","year":"2010","journal-title":"Pathology"},{"key":"B44","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/ajh.24235","article-title":"Evolution of sickle cell disease from a life-threatening disease of children to a chronic disease of adults: The last 40 years","volume":"91","author":"Chaturvedi","year":"2016","journal-title":"Am. J. Hematol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1126\/science.aat4346","article-title":"Single-particle cryo-EM-How did it get here and where will it go","volume":"361","author":"Cheng","year":"2018","journal-title":"Science"},{"key":"B46","doi-asserted-by":"publisher","first-page":"11901","DOI":"10.1021\/bi0202880","article-title":"Ligand binding properties and structural studies of recombinant and chemically modified hemoglobins altered at beta 93 cysteine","volume":"41","author":"Cheng","year":"2002","journal-title":"Biochemistry"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/phar.2329","article-title":"Systematic review of l-glutamine for prevention of vaso-occlusive pain crisis in patients with sickle cell disease","volume":"39","author":"Cieri-Hutcherson","year":"2019","journal-title":"Pharmacotherapy"},{"key":"B50","unstructured":"The FDA encourages new treatments for sickle cell disease2020"},{"key":"B51","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1006\/jmbi.1993.1195","article-title":"Double strand packing in hemoglobin S fibers","volume":"230","author":"Cretegny","year":"1993","journal-title":"J. Mol. Biol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1002\/anie.200200539","article-title":"Application and limitations of X-ray crystallographic data in structure-based ligand and drug design","volume":"42","author":"Davis","year":"2003","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"B53","doi-asserted-by":"publisher","first-page":"e2009024","DOI":"10.4084\/MJHID.2009.024","article-title":"Pathophisiology of sickle cell disease and new drugs for the treatment","volume":"1","author":"De Franceschi","year":"2009","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"key":"B54","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1177\/2472555220960401","article-title":"Cryo-EM: The resolution revolution and drug discovery","volume":"26","author":"de Oliveira","year":"2021","journal-title":"SLAS Discov."},{"key":"B55","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1107\/S2059798318009919","article-title":"Rational modification of vanillin derivatives to stereospecifically destabilize sickle hemoglobin polymer formation","volume":"74","author":"Deshpande","year":"2018","journal-title":"Acta. Crystallogr. D. Struct. Biol."},{"key":"B57","volume-title":"Principles of protein X-Ray crystallography","author":"Drenth","year":"2007"},{"key":"B58","doi-asserted-by":"publisher","first-page":"127524","DOI":"10.1016\/j.bmcl.2020.127524","article-title":"Cryo-EM as a powerful tool for drug discovery","volume":"30","author":"Drie","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B59","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3233\/CH-170340","article-title":"GBT440 improves red blood cell deformability and reduces viscosity of sickle cell blood under deoxygenated conditions","volume":"70","author":"Dufu","year":"2018","journal-title":"Clin. Hemorheol. Microcirc."},{"key":"B60","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1080\/15216540701272380","article-title":"Evolution of allosteric models for hemoglobin","volume":"59","author":"Eaton","year":"2007","journal-title":"IUBMB Life"},{"key":"B61","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/s0065-3233(08)60287-9","article-title":"Sickle cell hemoglobin polymerization","volume":"40","author":"Eaton","year":"1990","journal-title":"Adv. Protein Chem."},{"key":"B63","doi-asserted-by":"publisher","first-page":"3621","DOI":"10.1021\/acs.accounts.1c00279","article-title":"Toward compositional contrast by Cryo-STEM","volume":"54","author":"Elbaum","year":"2021","journal-title":"Acc. Chem. Res."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1021\/jm00394a007","article-title":"Design, synthesis, and testing of potential antisickling agents 10 (2,2-Dimethylchroman-6-yl)alkanoic acids","volume":"30","author":"Fatope","year":"1987","journal-title":"J. Med. Chem."},{"key":"B66","unstructured":"FDA approves hydroxyurea for treatment of pediatric patients with sickle cell anemia2019"},{"key":"B67","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/s0022-2836(75)80037-4","article-title":"Three-dimensional Fourier synthesis of human deoxyhaemoglobin at 2\u00b75 \u00c5 resolution: Refinement of the atomic model","volume":"97","author":"Fermi","year":"1975","journal-title":"J. Mol. Biol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1080\/10739680490278312","article-title":"Polymerization and sickle cell disease: A molecular view","volume":"11","author":"Ferrone","year":"2004","journal-title":"Microcirculation"},{"key":"B69","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/j.1365-2125.1985.tb02672.x","article-title":"The effects in volunteers of BW12C, a compound designed to left-shift the blood-oxygen saturation curve","volume":"19","author":"Fitzharris","year":"1985","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.jsb.2016.04.003","article-title":"Crystal structure of carbonmonoxy sickle hemoglobin in R-state conformation","volume":"194","author":"Ghatge","year":"2016","journal-title":"J. Struct. Biol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1080\/009841099157764","article-title":"Distribution and metabolism of (5-hydroxymethyl)furfural in male F344 rats and B6C3F1 mice after oral administration","volume":"57","author":"Godfrey","year":"1999","journal-title":"J. Toxicol. Environ. Health Part A"},{"key":"B73","doi-asserted-by":"publisher","first-page":"5140","DOI":"10.1021\/bi052424h","article-title":"Quaternary structure of carbonmonoxyhemoglobins in solution: Structural changes induced by the allosteric effector inositol hexaphosphate","volume":"45","author":"Gong","year":"2006","journal-title":"Biochemistry"},{"key":"B74","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/978-1-4615-0075-9_27","article-title":"\u201cThe dose-dependent effect of RSR13, a synthetic allosteric modifier of hemoglobin, on physiological parameters and brain tissue oxygenation in rats","volume-title":"Oxygen transport to tissue XXIV advances in experimental medicine and biology","author":"Grinberg","year":"2003"},{"key":"B75","doi-asserted-by":"publisher","first-page":"8250","DOI":"10.1016\/s0021-9258(19)86883-7","article-title":"Location of the allosteric site for 2,3-bisphosphoglycerate on human oxy- and deoxyhemoglobin as observed by magnetic resonance spectroscopy","volume":"254","author":"Gupta","year":"1979","journal-title":"J. Biol. Chem."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/s11030-021-10217-3","article-title":"Artificial intelligence to deep learning: Machine intelligence approach for drug discovery","volume":"25","author":"Gupta","year":"2021","journal-title":"Mol. Divers."},{"key":"B77","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1177\/1535370216636726","article-title":"Minireview: Genetic basis of heterogeneity and severity in sickle cell disease","volume":"241","author":"Habara","year":"2016","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"B78","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1006\/jmbi.1997.1253","article-title":"The high resolution crystal structure of deoxyhemoglobin S","volume":"272","author":"Harrington","year":"1997","journal-title":"J. Mol. Biol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1006\/jmbi.1995.0419","article-title":"The structure of deoxy- and oxy-leghaemoglobin from lupin","volume":"251","author":"Harutyunyan","year":"1995","journal-title":"J. Mol. Biol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.freeradbiomed.2013.04.028","article-title":"Hemoglobin-mediated nitric oxide signaling","volume":"61","author":"Helms","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"B83","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/s0301-4622(02)00091-1","article-title":"A tertiary two-state allosteric model for hemoglobin","volume":"98","author":"Henry","year":"2002","journal-title":"Biophys. Chem."},{"key":"B84","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1001\/archinte.1910.00050330050003","article-title":"Peculiar elongated and sickle-shaped red blood corpuscules in a case of severe anemia","volume":"4","author":"Herrick","year":"1910","journal-title":"Arch. Intern. Med."},{"key":"B85","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0167-8140(89)90118-7","article-title":"Altered radiosensitivity in a mouse carcinoma after administration of clofibrate and bezafibrate","volume":"15","author":"Hirst","year":"1989","journal-title":"Radiother. Oncol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"164","DOI":"10.2307\/3577087","article-title":"The modification of hemoglobin affinity for oxygen and tumor radiosensitivity by antilipidemic drugs","volume":"112","author":"Hirst","year":"1987","journal-title":"Radiat. Res."},{"key":"B87","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1021\/jf60015a004","article-title":"Dehydrated foods, chemistry of browning reactions in model systems","volume":"1","author":"Hodge","year":"1953","journal-title":"J. Agric. Food Chem."},{"key":"B88","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/s0096-5332(08)60392-6","article-title":"The Amadori rearrangement","volume":"10","author":"Hodge","year":"1955","journal-title":"Adv. Carbohydr. Chem. ed. M. L. Wolfrom Acad. Press)"},{"key":"B89","doi-asserted-by":"publisher","first-page":"8521","DOI":"10.1073\/pnas.87.21.8521","article-title":"Expression of fully functional tetrameric human hemoglobin in Escherichia coli","volume":"87","author":"Hoffman","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B91","doi-asserted-by":"publisher","first-page":"6835","DOI":"10.3390\/molecules27206835","article-title":"Design, synthesis, and investigation of novel nitric oxide (NO)-releasing aromatic aldehydes as drug candidates for the treatment of sickle cell disease","volume":"27","author":"Huang","year":"2022","journal-title":"Molecules"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1021\/bi981986g","article-title":"Structural and functional properties of human hemoglobins reassembled after synthesis in Escherichia coli","volume":"38","author":"Hui","year":"1999","journal-title":"Biochemistry"},{"key":"B93","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.transci.2005.09.005","article-title":"Oxygen carriers: A selected review","volume":"34","author":"Inayat","year":"2006","journal-title":"Transfus. Apher. Sci."},{"key":"B94","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/0006-3002(58)90516-x","article-title":"Abnormal human haemoglobins. I. The comparison of normal human and sickle-cell haemoglobins by fingerprinting","volume":"28","author":"Ingram","year":"1958","journal-title":"Biochim. Biophys. Acta"},{"key":"B95","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/180326a0","article-title":"Gene mutations in human haemoglobin: The chemical difference between normal and sickle cell haemoglobin","volume":"180","author":"Ingram","year":"1957","journal-title":"Nature"},{"key":"B96","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1107\/S0907444908037256","article-title":"Structure of relaxed-state human hemoglobin: Insight into ligand uptake, transport and release","volume":"65","author":"Jenkins","year":"2009","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"B97","doi-asserted-by":"publisher","first-page":"3387","DOI":"10.1242\/jeb.023697","article-title":"The dual roles of red blood cells in tissue oxygen delivery: Oxygen carriers and regulators of local blood flow","volume":"212","author":"Jensen","year":"2009","journal-title":"J. Exp. Biol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"B101","doi-asserted-by":"publisher","first-page":"559","DOI":"10.2165\/00023210-200721070-00003","article-title":"CNS complications of breast cancer: Current and emerging treatment options","volume":"21","author":"Kaal","year":"2007","journal-title":"CNS Drugs"},{"key":"B102","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1097\/MOH.0000000000000241","article-title":"New insights into sickle cell disease: Mechanisms and investigational therapies","volume":"23","author":"Kato","year":"2016","journal-title":"Curr. Opin. Hematol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.blre.2006.07.001","article-title":"Deconstructing sickle cell disease: Reappraisal of the role of hemolysis in the development of clinical subphenotypes","volume":"21","author":"Kato","year":"2007","journal-title":"Blood Rev."},{"key":"B104","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1182\/blood.v122.21.1009.1009","article-title":"Phase 1 clinical trial of the candidate anti-sickling agent Aes-103 in adults with sickle cell anemia","volume":"122","author":"Kato","year":"2013","journal-title":"Blood"},{"key":"B105","doi-asserted-by":"publisher","first-page":"4111","DOI":"10.1021\/bi00131a030","article-title":"High-resolution X-ray study of deoxyhemoglobin rothschild 37 beta trp\u2013arg: A mutation that creates an intersubunit chloride-binding site","volume":"31","author":"Kavanaugh","year":"1992","journal-title":"Biochemistry"},{"key":"B106","doi-asserted-by":"publisher","first-page":"4358","DOI":"10.1021\/bi9708702","article-title":"High-resolution crystal structures of human hemoglobin with mutations at tryptophan 37beta: Structural basis for a high-affinity T-state","volume":"37","author":"Kavanaugh","year":"1998","journal-title":"Biochemistry"},{"key":"B107","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1110\/ps.16401","article-title":"Site-directed mutations of human hemoglobin at residue 35beta: A residue at the intersection of the alpha1beta1, alpha1beta2, and alpha1alpha2 interfaces","volume":"10","author":"Kavanaugh","year":"2001","journal-title":"Protein Sci."},{"key":"B108","doi-asserted-by":"publisher","first-page":"086501","DOI":"10.1117\/1.JBO.26.8.086501","article-title":"Hemoglobin quantification in red blood cells via dry mass mapping based on UV absorption","volume":"26","author":"Kaza","year":"2021","journal-title":"J. Biomed. Opt."},{"key":"B109","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/s0140-6736(86)90941-4","article-title":"Effect of BW12C on oxygen affinity of haemoglobin in sickle-cell disease","volume":"1","author":"Keidan","year":"1986","journal-title":"Lancet"},{"key":"B110","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/181662a0","article-title":"A three-dimensional model of the myoglobin molecule obtained by x-ray analysis","volume":"181","author":"Kendrew","year":"1958","journal-title":"Nature"},{"key":"B111","doi-asserted-by":"publisher","first-page":"H1450","DOI":"10.1152\/ajpheart.1993.265.4.H1450","article-title":"Enhanced oxygenation in vivo by allosteric inhibitors of hemoglobin saturation","volume":"265","author":"Khandelwal","year":"1993","journal-title":"Am. J. Physiol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"15669","DOI":"10.1021\/bi011329f","article-title":"The role of beta chains in the control of the hemoglobin oxygen binding function: Chimeric human\/mouse proteins, structure, and function","volume":"40","author":"Kidd","year":"2001","journal-title":"Biochemistry"},{"key":"B113","doi-asserted-by":"publisher","first-page":"6411","DOI":"10.1074\/jbc.274.10.6411","article-title":"The structural and functional analysis of the hemoglobin D component from chicken","volume":"274","author":"Knapp","year":"1999","journal-title":"J. Biol. Chem."},{"key":"B114","article-title":"Pharmaceutical compounds, preparation, use and intermediates therefor and their preparation. U. S. Patent No 4535183A","author":"Kneen","year":"1985"},{"key":"B115","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1021\/bi00865a047","article-title":"Comparison of experimental binding data and theoretical models in proteins containing subunits","volume":"5","author":"Koshland","year":"1966","journal-title":"Biochemistry"},{"key":"B116","doi-asserted-by":"publisher","first-page":"H602","DOI":"10.1152\/ajpheart.1996.271.2.H602","article-title":"RSR-13, an allosteric effector of hemoglobin, increases systemic and iliac vascular resistance in rats","volume":"271","author":"Kunert","year":"1996","journal-title":"Am. J. Physiol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/0022-2836(77)90256-x","article-title":"The structure of horse methaemoglobin at 2-0 A resolution","volume":"114","author":"Ladner","year":"1977","journal-title":"J. Mol. Biol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1016\/j.drudis.2019.07.006","article-title":"Deep learning in drug discovery: Opportunities, challenges and future prospects","volume":"24","author":"Lavecchia","year":"2019","journal-title":"Drug Discov. Today"},{"key":"B119","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/genetics\/153.1.1","article-title":"J. B. S. Haldane (1949) on infectious disease and evolution","volume":"153","author":"Lederberg","year":"1999","journal-title":"Genetics"},{"key":"B121","doi-asserted-by":"publisher","first-page":"E56","DOI":"10.3390\/molecules24010056","article-title":"Characterization, variables, and antioxidant activity of the maillard reaction in a fructose-histidine model system","volume":"24","author":"Liu","year":"2018","journal-title":"Molecules"},{"key":"B122","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.3389\/fphys.2019.01350","article-title":"Increased hemoglobin oxygen affinity with 5-Hydroxymethylfurfural supports cardiac function during severe hypoxia","volume":"10","author":"Lucas","year":"2019","journal-title":"Front. Physiol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1073\/pnas.232715799","article-title":"Quaternary structure of hemoglobin in solution","volume":"100","author":"Lukin","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B124","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1111\/j.1365-2044.1977.tb10002.x","article-title":"Red cell 2,3-diphosphoglycerate and oxygen affinity","volume":"32","author":"Macdonald","year":"1977","journal-title":"Anaesthesia"},{"key":"B125","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1227\/01.neu.0000182742.40978.e7","article-title":"Current strategies in whole-brain radiation therapy for brain metastases","volume":"57","author":"Mehta","year":"2005","journal-title":"Neurosurgery"},{"key":"B126","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1182\/blood.v122.21.940.940","article-title":"The anti-sickling agent Aes-103 decreases sickle erythrocyte fragility, hypoxia-induced sickling and hemolysis in vitro","volume":"122","author":"Mendelsohn","year":"2013","journal-title":"Blood"},{"key":"B127","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1042\/bj2390387","article-title":"Characterization of the binding of the anti-sickling compound, BW12C, to haemoglobin","volume":"239","author":"Merrett","year":"1986","journal-title":"Biochem. J."},{"key":"B128","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1021\/acsmedchemlett.6b00491","article-title":"Discovery of GBT440, an orally bioavailable R-state stabilizer of sickle cell hemoglobin","volume":"8","author":"Metcalf","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"B129","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/s0022-2836(65)80285-6","article-title":"On the nature of allosteric transitions: A plausible model","volume":"12","author":"Monod","year":"1965","journal-title":"J. Mol. Biol."},{"key":"B131","doi-asserted-by":"crossref","DOI":"10.1002\/9781119975427","volume-title":"Chemistry and Biochemistry of oxygen therapeutics: From transfusion to artificial blood","author":"Mozzarelli","year":"2011"},{"key":"B132","doi-asserted-by":"publisher","first-page":"15353","DOI":"10.1021\/bi0012944","article-title":"Interface sliding as illustrated by the multiple quaternary structures of liganded hemoglobin","volume":"39","author":"Mueser","year":"2000","journal-title":"Biochemistry"},{"key":"B133","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/228516a0","article-title":"Three-dimensional Fourier synthesis of human deoxyhaemoglobin at 3.5 Angstrom units","volume":"228","author":"Muirhead","year":"1970","journal-title":"Nature"},{"key":"B134","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/199633a0","article-title":"Structure of h\u00e6emoglobin: A three-dimensional fourier synthesis of reduced human haemoglobin at 5.5 \u00c5 resolution","volume":"199","author":"Muirhead","year":"1963","journal-title":"Nature"},{"key":"B137","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1182\/bloodadvances.2018GS110347","article-title":"Increasing hydroxyurea use in children with sickle cell disease at Kamuzu Central Hospital, Malawi","volume":"2","author":"Mvalo","year":"2018","journal-title":"Blood Adv."},{"key":"B139","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/(sici)1096-8652(199806)58:2<117:aid-ajh5>3.0.co;2-v","article-title":"Oral L-glutamine therapy for sickle cell anemia: I. Subjective clinical improvement and favorable change in red cell NAD redox potential","volume":"58","author":"Niihara","year":"1998","journal-title":"Am. J. Hematol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1002\/cbdv.200890165","article-title":"Pyridyl derivatives of benzaldehyde as potential antisickling agents","volume":"5","author":"Nnamani","year":"2008","journal-title":"Chem. Biodivers."},{"key":"B141","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/bjh.14264","article-title":"New developments in anti-sickling agents: Can drugs directly prevent the polymerization of sickle haemoglobin in vivo?","volume":"175","author":"Oder","year":"2016","journal-title":"Br. J. Haematol."},{"key":"B142","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/bjh.14214","article-title":"GBT440 increases haemoglobin oxygen affinity, reduces sickling and prolongs RBC half-life in a murine model of sickle cell disease","volume":"175","author":"Oksenberg","year":"2016","journal-title":"Br. J. Haematol."},{"key":"B143","doi-asserted-by":"publisher","first-page":"14724","DOI":"10.1021\/acs.jmedchem.0c01287","article-title":"Exploration of structure\u2013activity relationship of aromatic aldehydes bearing pyridinylmethoxy-methyl esters as novel antisickling agents","volume":"63","author":"Pagare","year":"2020","journal-title":"J. Med. Chem."},{"key":"B144","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1016\/j.bmc.2018.04.015","article-title":"Rational design of pyridyl derivatives of vanillin for the treatment of sickle cell disease","volume":"26","author":"Pagare","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"B145","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1080\/13543776.2022.1994945","article-title":"Modulating hemoglobin allostery for treatment of sickle cell disease: Current progress and intellectual property","volume":"32","author":"Pagare","year":"2022","journal-title":"Expert Opin. Ther. Pat."},{"key":"B146","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1023\/A:1027310719146","article-title":"Protein structure from X-ray diffraction","volume":"29","author":"Parker","year":"2003","journal-title":"J. Biol. Phys."},{"key":"B147","doi-asserted-by":"publisher","first-page":"5277","DOI":"10.3390\/molecules25225277","article-title":"Machine learning methods in drug discovery","volume":"25","author":"Patel","year":"2020","journal-title":"Molecules"},{"key":"B148","first-page":"334","article-title":"Molecular disease and evolution","volume":"40","author":"Pauling","year":"1964","journal-title":"Bull. N. Y. Acad. Med."},{"key":"B149","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1126\/science.110.2865.543","article-title":"Sickle cell anemia a molecular disease","volume":"110","author":"Pauling","year":"1949","journal-title":"Science"},{"key":"B150","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s11864-006-0023-8","article-title":"Current therapeutic approaches in patients with brain metastases","volume":"7","author":"Peacock","year":"2006","journal-title":"Curr. Treat. Options. Oncol."},{"key":"B151","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1021\/bi9519967","article-title":"Crystallographic, molecular modeling, and biophysical characterization of the valine beta 67 (E11)-->threonine variant of hemoglobin","volume":"35","author":"Pechik","year":"1996","journal-title":"Biochemistry"},{"key":"B152","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/s0300-9084(72)80142-1","article-title":"Stereochemical mechanism of cooperative effects in haemoglobin","volume":"54","author":"Perutz","year":"1972","journal-title":"Biochim."},{"key":"B153","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1093\/oxfordjournals.bmb.a071363","article-title":"Structure and mechanism of haemoglobin","volume":"32","author":"Perutz","year":"1976","journal-title":"Br. Med. Bull."},{"key":"B154","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1006\/jmbi.1993.1530","article-title":"A novel allosteric mechanism in haemoglobin. Structure of bovine deoxyhaemoglobin, absence of specific chloride-binding sites and origin of the chloride-linked Bohr effect in bovine and human haemoglobin","volume":"233","author":"Perutz","year":"1993","journal-title":"J. Mol. Biol."},{"key":"B155","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/219131a0","article-title":"Three-dimensional Fourier synthesis of horse oxyhaemoglobin at 2.8 \u00c5 resolution: The atomic model","volume":"219","author":"Perutz","year":"1968","journal-title":"Nature"},{"key":"B157","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/185416a0","article-title":"Structure of h\u00e6moglobin: A three-dimensional fourier synthesis at 5.5-\u00e5. Resolution, obtained by X-ray analysis","volume":"185","author":"Perutz","year":"1960","journal-title":"Nature"},{"key":"B158","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev.biophys.27.1.1","article-title":"The stereochemical mechanism of the cooperative effects in hemoglobin revisited","volume":"27","author":"Perutz","year":"1998","journal-title":"Annu. Rev. Biophys. Biomol. Struct."},{"key":"B159","doi-asserted-by":"publisher","first-page":"4726","DOI":"10.1021\/jm000199q","article-title":"Synthesis and structure-activity relationships of chiral allosteric modifiers of hemoglobin","volume":"43","author":"Phelps Grella","year":"2000","journal-title":"J. Med. Chem."},{"key":"B160","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1056\/NEJMra1510865","article-title":"Sickle cell disease","volume":"376","author":"Piel","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"B161","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/08830180701848995","article-title":"Paul ehrlich: The Nobel prize in physiology or medicine 1908","volume":"27","author":"Piro","year":"2008","journal-title":"Int. Rev. Immunol."},{"key":"B162","article-title":"Oxygen transport","volume-title":"Regulation of tissue oxygenation","author":"Pittman","year":"2011"},{"key":"B163","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1182\/blood.v76.5.1028.1028","article-title":"2,3-Diphosphoglycerate and intracellular pH as interdependent determinants of the physiologic solubility of deoxyhemoglobin S","volume":"76","author":"Poillon","year":"1990","journal-title":"Blood"},{"key":"B164","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/0003-9861(86)90006-8","article-title":"The effect of 2,3-diphosphoglycerate on the solubility of deoxyhemoglobin S","volume":"249","author":"Poillon","year":"1986","journal-title":"Arch. Biochem. Biophys."},{"key":"B166","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1021\/jm00106a041","article-title":"Allosteric modifiers of hemoglobin. 1. Design, synthesis, testing, and structure-allosteric activity relationship of novel hemoglobin oxygen affinity decreasing agents","volume":"34","author":"Randad","year":"1991","journal-title":"J. Med. Chem."},{"key":"B167","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","article-title":"Sickle-cell disease","volume":"376","author":"Rees","year":"2010","journal-title":"Lancet"},{"key":"B168","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/nrd.2018.77","article-title":"Cryo-EM in drug discovery: Achievements, limitations and prospects","volume":"17","author":"Renaud","year":"2018","journal-title":"Nat. Rev. Drug. Discov."},{"key":"B169","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/s0006-291x(83)80109-0","article-title":"Sickle cell hemoglobin fiber formation strongly inhibited by the Stanleyville II mutation (alpha 78 Asn leads to Lys)","volume":"111","author":"Rhoda","year":"1983","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B171","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1046\/j.1365-2249.2002.02016.x","article-title":"Discovery of immunopotentiatory drugs: Current and future strategies","volume":"130","author":"Rhodes","year":"2002","journal-title":"Clin. Exp. Immunol."},{"key":"B172","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1006\/jmbi.1993.1505","article-title":"Human deoxyhaemoglobin-2,3-diphosphoglycerate complex low-salt structure at 2.5 A resolution","volume":"233","author":"Richard","year":"1993","journal-title":"J. Mol. Biol."},{"key":"B173","unstructured":"Atlas of molecular structures in biology. 1. Ribonuclease-S\n            RichardsF. M.\n            WyckoffH. W.\n          1973"},{"key":"B174","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1182\/blood-2012-02-414037","article-title":"Sickle hemoglobin disturbs normal coupling among erythrocyte O2 content, glycolysis, and antioxidant capacity","volume":"121","author":"Rogers","year":"2013","journal-title":"Blood"},{"key":"B175","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/j.1365-2125.1995.tb04465.x","article-title":"Pharmacokinetics and pharmacodynamics of tucaresol, an antisickling agent, in healthy volunteers","volume":"39","author":"Rolan","year":"1995","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B176","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/j.1365-2125.1993.tb04160.x","article-title":"The pharmacokinetics, tolerability and pharmacodynamics of tucaresol (589C80; 4[2-formyl-3-hydroxyphenoxymethyl] benzoic acid), a potential anti-sickling agent, following oral administration to healthy subjects","volume":"35","author":"Rolan","year":"1993","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B177","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.ijrobp.2005.10.013","article-title":"Radiation sensitization with redox modulators: A promising approach","volume":"64","author":"Rosenberg","year":"2006","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"B178","article-title":"Anti-sickling agents","author":"Safo","year":"2004"},{"key":"B179","article-title":"Aromatic aldehydes with sustained and enhanced in vitro and in vivo pharmacologic activity to treat sickle cell disease","author":"Safo","year":"2021"},{"key":"B180","doi-asserted-by":"publisher","first-page":"4665","DOI":"10.1021\/jm0498001","article-title":"Structural basis for the potent antisickling effect of a novel class of five-membered heterocyclic aldehydic compounds","volume":"47","author":"Safo","year":"2004","journal-title":"J. Med. Chem."},{"key":"B181","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1107\/S0907444904030501","article-title":"Structures of R- and T-state hemoglobin bassett: Elucidating the structural basis for the low oxygen affinity of a mutant hemoglobin","volume":"61","author":"Safo","year":"2005","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"B182","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1110\/ps.48301","article-title":"The X-ray structure determination of bovine carbonmonoxy hemoglobin at 2.1 A resoultion and its relationship to the quaternary structures of other hemoglobin crystal froms","volume":"10","author":"Safo","year":"2001","journal-title":"Protein Sci."},{"key":"B183","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1385\/1-59259-373-9:001","article-title":"X-Ray crystallography of hemoglobins","volume-title":"Hemoglobin disorders methods in molecular BiologyTM","author":"Safo","year":"2003"},{"key":"B184","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.bbapap.2011.02.013","article-title":"Hemoglobin-ligand binding: Understanding Hb function and allostery on atomic level","volume":"1814","author":"Safo","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"B185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/0471266949.bmc270","article-title":"Therapeutic strategies for the treatment of sickle cell disease","volume-title":"Burger\u2019s medicinal chemistry and drug discovery","author":"Safo","year":"2021"},{"key":"B186","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1107\/s0907444902002627","article-title":"X-Ray crystallographic analyses of symmetrical allosteric effectors of hemoglobin: Compounds designed to link primary and secondary binding sites","volume":"58","author":"Safo","year":"","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"B187","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/9781119975427.ch21","article-title":"Allosteric effectors of hemoglobin: Past, present and future","volume-title":"Chemistry and Biochemistry of oxygen therapeutics","author":"Safo","year":"2011"},{"key":"B188","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1107\/s0907444902015809","article-title":"Structure of human carbonmonoxyhemoglobin at 2.16 A: A snapshot of the allosteric transition","volume":"58","author":"Safo","year":"","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"B189","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.hoc.2013.11.001","article-title":"Therapeutic strategies to alter the oxygen affinity of sickle hemoglobin","volume":"28","author":"Safo","year":"2014","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"B190","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1110\/ps.50601","article-title":"High-resolution crystal structure of deoxy hemoglobin complexed with a potent allosteric effector","volume":"10","author":"Safo","year":"2001","journal-title":"Protein Sci."},{"key":"B192","unstructured":"A phase 1, placebo-controlled, randomized, double-blind study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of escalating, single oral doses of aes-103 in subjects with stable sickle cell disease2021"},{"key":"B193","doi-asserted-by":"publisher","first-page":"3927","DOI":"10.1182\/blood-2008-04-078188","article-title":"Hemoglobin research and the origins of molecular medicine","volume":"112","author":"Schechter","year":"2008","journal-title":"Blood"},{"key":"B194","first-page":"3395","article-title":"Clofibrate demonstrates efficacy in in vitro treatment of lymphoma and multiple myeloma","volume":"36","author":"Schmeel","year":"2016","journal-title":"Anticancer Res."},{"key":"B196","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1097\/COC.0b013e3180653c0d","article-title":"Improved survival, quality of life, and quality-adjusted survival in breast cancer patients treated with efaproxiral (Efaproxyn) plus whole-brain radiation therapy for brain metastases","volume":"30","author":"Scott","year":"2007","journal-title":"Am. J. Clin. Oncol."},{"key":"B198","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/prot.340100202","article-title":"The mutation beta 99 Asp-Tyr stabilizes Y\u2013a new, composite quaternary state of human hemoglobin","volume":"10","author":"Smith","year":"1991","journal-title":"Proteins"},{"key":"B199","unstructured":"Socalcycling2012"},{"key":"B200","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.ijrobp.2005.10.004","article-title":"Whole-brain radiotherapy with or without efaproxiral for the treatment of brain metastases: Determinants of response and its prognostic value for subsequent survival","volume":"64","author":"Stea","year":"2006","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"B201","doi-asserted-by":"publisher","first-page":"3210","DOI":"10.1182\/blood.v120.21.3210.3210","article-title":"A phase 1, first-in-man, dose-response study of aes-103 (5-HMF), an anti-sickling, allosteric modifier of hemoglobin oxygen affinity in healthy norman volunteers","volume":"120","author":"Stern","year":"2012","journal-title":"Blood"},{"key":"B202","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1200\/JCO.2004.00.1768","article-title":"Phase III study of efaproxiral as an adjunct to whole-brain radiation therapy for brain metastases","volume":"24","author":"Suh","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"B203","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1107\/S2053230X2100306X","article-title":"Crystal structure of hemoglobin from mouse (Mus musculus) compared with those from other small animals and humans","volume":"77","author":"Sundaresan","year":"2021","journal-title":"Acta Crystallogr. F. Struct. Biol. Commun."},{"key":"B204","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/0022-2836(72)90077-0","article-title":"A mathematical model for structure-function relations in hemoglobin","volume":"72","author":"Szabo","year":"1972","journal-title":"J. Mol. Biol."},{"key":"B205","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1107\/s0907444900006387","article-title":"The structures of deoxy human haemoglobin and the mutant Hb Tyralpha42His at 120 K","volume":"56","author":"Tame","year":"2000","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"B207","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1182\/blood-2015-09-618553","article-title":"Beyond hydroxyurea: New and old drugs in the pipeline for sickle cell disease","volume":"127","author":"Telen","year":"2016","journal-title":"Blood"},{"key":"B208","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pathol.2016.10.002","article-title":"Sickle cell disease in the older adult","volume":"49","author":"Thein","year":"2017","journal-title":"Pathology"},{"key":"B211","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1021\/cr300182k","article-title":"Hydroxymethylfurfural, a versatile platform chemical made from renewable resources","volume":"113","author":"van Putten","year":"2013","journal-title":"Chem. Rev."},{"key":"B212","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0009-2797(00)00211-8","article-title":"Role of aldehyde dehydrogenases in endogenous and xenobiotic metabolism","volume":"129","author":"Vasiliou","year":"2000","journal-title":"Chem. Biol. Interact."},{"key":"B213","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1107\/s0907444997012250","article-title":"Human carboxyhemoglobin at 2.2 A resolution: Structure and solvent comparisons of R-state, R2-state and T-state hemoglobins","volume":"54","author":"V\u00e1squez","year":"1998","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"B214","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S0006-3495(99)77180-8","article-title":"Cysteines beta93 and beta112 as probes of conformational and functional events at the human hemoglobin subunit interfaces","volume":"76","author":"V\u00e1squez","year":"1999","journal-title":"Biophys. J."},{"key":"B215","doi-asserted-by":"publisher","first-page":"12682","DOI":"10.1016\/s0021-9258(18)42331-9","article-title":"Hemoglobin Thionville. An alpha-chain variant with a substitution of a glutamate for valine at NA-1 and having an acetylated methionine NH2 terminus","volume":"267","author":"Vasseur","year":"1992","journal-title":"J. Biol. Chem."},{"key":"B216","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1107\/S2053230X17003740","article-title":"Cryo-electron microscopy and X-ray crystallography: Complementary approaches to structural biology and drug discovery","volume":"73","author":"V\u00e9nien-Bryan","year":"2017","journal-title":"Acta Crystallogr. F. Struct. Biol. Commun."},{"key":"B217","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1756-9966-28-1","article-title":"Whole brain radiotherapy with radiosensitizer for brain metastases","volume":"28","author":"Viani","year":"2009","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B218","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1056\/NEJMoa1903212","article-title":"A Phase 3 randomized trial of Voxelotor in sickle cell disease","volume":"381","author":"Vichinsky","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"B219","doi-asserted-by":"publisher","first-page":"5854","DOI":"10.1128\/AEM.01291-08","article-title":"Enhancement of recombinant hemoglobin production in Escherichia coli BL21(DE3) containing the Plesiomonas shigelloides heme transport system","volume":"74","author":"Villarreal","year":"2008","journal-title":"Appl. Environ. Microbiol."},{"key":"B220","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0140-6736(17)30193-9","article-title":"Sickle cell disease","volume":"390","author":"Ware","year":"2017","journal-title":"Lancet"},{"key":"B221","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1172\/JCI104747","article-title":"Is hemoglobin an essential structural component of human erythrocyte membranes?","volume":"42","author":"Weed","year":"1963","journal-title":"J. Clin. Invest."},{"key":"B222","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1073\/pnas.88.6.2209","article-title":"X-ray diffraction study of the binding of the antisickling agent 12C79 to human hemoglobin","volume":"88","author":"Wireko","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B223","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1021\/acs.molpharmaceut.7b00553","article-title":"Design, synthesis, and biological evaluation of ester and ether derivatives of antisickling agent 5-HMF for the treatment of sickle cell disease","volume":"14","author":"Xu","year":"2017","journal-title":"Mol. Pharm."},{"key":"B224","doi-asserted-by":"publisher","first-page":"34508","DOI":"10.1074\/jbc.M203135200","article-title":"Global allostery model of hemoglobin. Modulation of O(2) affinity, cooperativity, and Bohr effect by heterotropic allosteric effectors","volume":"277","author":"Yonetani","year":"2002","journal-title":"J. Biol. Chem."},{"key":"B225","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1046\/j.1432-1327.1998.2510549.x","article-title":"Human aldehyde dehydrogenase gene family","volume":"251","author":"Yoshida","year":"1998","journal-title":"Eur. J. Biochem."},{"key":"B226","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1021\/jm010358l","article-title":"Synthesis and X-ray studies of chiral allosteric modifiers of hemoglobin","volume":"45","author":"Youssef","year":"2002","journal-title":"J. Med. Chem."},{"key":"B227","doi-asserted-by":"publisher","first-page":"8542","DOI":"10.1016\/s0021-9258(19)75254-5","article-title":"Schiff base adducts of hemoglobin. Modifications that inhibit erythrocyte sickling","volume":"252","author":"Zaugg","year":"1977","journal-title":"J. Biol. Chem."},{"key":"B228","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.1016\/s0021-9258(19)85812-x","article-title":"Modification of hemoglobin with analogs of aspirin","volume":"255","author":"Zaugg","year":"1980","journal-title":"J. Biol. Chem."}],"container-title":["Frontiers in Molecular Biosciences"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2023.1136970\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T05:33:20Z","timestamp":1684906400000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2023.1136970\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,24]]},"references-count":197,"alternative-id":["10.3389\/fmolb.2023.1136970"],"URL":"https:\/\/doi.org\/10.3389\/fmolb.2023.1136970","relation":{},"ISSN":["2296-889X"],"issn-type":[{"value":"2296-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,24]]},"article-number":"1136970"}}